Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
342
-
Total 13F shares, excl. options
-
46.3M
-
Shares change
-
-346K
-
Total reported value, excl. options
-
$5.19B
-
Value change
-
-$31.3M
-
Put/Call ratio
-
0.47
-
Number of buys
-
166
-
Number of sells
-
-140
-
Price
-
$112.26
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q2 2018
374 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q2 2018.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 342 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.3M shares
of 50.5M outstanding shares and own 91.66% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.25M shares), BlackRock Inc. (4.45M shares), FIL Ltd (1.75M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.67M shares), AQR CAPITAL MANAGEMENT LLC (1.62M shares), RENAISSANCE TECHNOLOGIES LLC (1.52M shares), ARIEL INVESTMENTS, LLC (1.32M shares), WELLS FARGO & COMPANY/MN (1.32M shares), FMR LLC (1.23M shares), and STATE STREET CORP (1.2M shares).
This table shows the top 342 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.